Aurora Cannabis (ACB) Other Working Capital Changes (2017 - 2018)
Aurora Cannabis (ACB) posted quarterly Other Working Capital Changes of $5.7 million for Q4 2024, up 279.96% year-on-year from $1.5 million in Q1 2024, and up 410.31% on a QoQ basis from -$1.8 million in Q2 2024.
Aurora Cannabis (ACB) Other Working Capital Changes (2017 - 2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Working Capital Changes for 2 consecutive years, with -$6.7 million the latest figure, recorded in Q4 2018.
- Quarterly Other Working Capital Changes rose 279.96% year-over-year to $5.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$8.6 million (up 48.42% YoY) and the FY2023 annual result came in at -$83378.7, up 99.73% from the prior year.
- Other Working Capital Changes grew to $5.7 million in Q4 2024 per ACB's latest filing, from -$1.8 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for ACB reached as high as $35.4 million in Q1 2020 and fell as low as -$22.8 million in Q3 2021.
- A 5-year average of -$1.4 million and a median of -$3.2 million in 2023 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 1535.79% in 2018 against a maximum downside of 5455.36% in 2018.
- Year by year, Other Working Capital Changes stood at -$10.4 million in 2020, then surged by 67.54% to -$3.4 million in 2021, then tumbled by 129.82% to -$7.7 million in 2022, then jumped by 58.98% to -$3.2 million in 2023, then jumped by 279.96% to $5.7 million in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $5.7 million, -$1.8 million, and -$3.2 million for Q4 2024, Q2 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -6.70 Mn |
| Dec 31, 2018 | -6.70 Mn |
| Dec 31, 2018 | -6.70 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Sep 30, 2018 | -6.33 Mn |
| Dec 31, 2017 | 466,775.35 |
| Dec 31, 2017 | 466,775.35 |
| Dec 31, 2017 | 466,775.35 |
| Sep 30, 2017 | -114,029.11 |
| Sep 30, 2017 | -114,029.11 |
| Sep 30, 2017 | -114,029.11 |